97186 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
METHODS FOR INHIBITING DIAZEPAM BINDING PROTEIN
#2MONOCLONAL ANTIBODIES FOR TARGETING THE CARDIAC CONDUCTION SYSTEM
#3MULTISPECIFIC BINDING AGENTS TARGETING DOPAMINE RECEPTOR D2 AND METHODS OF USE THEREOF
#4ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF
#5METHODS OF DIAGNOSING, DETERMINING THE PROGRESSION OF, AND TREATING A PROSTATE CANCER
#6AGENT, USES AND METHODS FOR TREATMENT
#7TREATMENT OF HEADACHE DISORDERS WITH NK3 MODULATORS
#8METHODS AND SYSTEMS FOR IDENTIFYING OR TREATING CENTRAL NERVOUS SYSTEMS DISEASE
#9CANNABINOID RECEPTOR TYPE 1 (CB1) BINDING PROTEINS AND USES THEREOF
#10METHODS OF USE OF ANTI-SORTILIN ANTIBODIES
#11ANTI-ADENOSINE RECEPTOR (A2aR) ANTIBODIES AND THE USE THEREOF
#12ANTI-NMDA RECEPTOR ANTIBODIES AND METHODS OF USE
#13Methods and Compositions Relating to Adenosine Receptors
#14METHODS OF USE OF ANTI-SORTILIN ANTIBODIES FOR TREATING A DISEASE, DISORDER, OR INJURY
#15ANTI-NMDAR2B ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND CHIMERIC ANTIGEN RECEPTORS, AND COMPOSITIONS AND METHODS OF USE
#16MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES
#17DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#18METHODS OF USE OF ANTI-SORTILIN ANTIBODIES FOR TREATING A DISEASE, DISORDER, OR INJURY
#19METHODS FOR INHIBITING DIAZEPAM BINDING PROTEIN
#20GENE CODING FOR CHIMERIC RECEPTOR FOR ANTI-ACETYLCHOLINE RECEPTOR AUTOANTIBODY
#21METHODS OF USE OF ANTI-SORTILIN ANTIBODIES
#22TREATMENT OF CVD AND SYSTEMIC SCEROSIS WITH BETA-1 ADRENERGIC RECEPTOR ANTIBODIES
#23METHODS OF USE OF ANTI-SORTILIN ANTIBODIES
#24METHODS FOR TREATING AND MONITORING FRONTOTEMPORAL DEMENTIA
#25Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs
#26TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES
#27COMPOSITIONS AND METHODS FOR INHIBITION OF NATURAL KILLER CELL RECEPTORS
#28A SORTILIN ANTAGONIST FOR USE IN THE PREVENTION OR TREATMENT OF HEARING LOSS
#29Method And System For Identifying And Validating Shared Candidate Antigens And Shared Antigen-Specific T Lymphocyte Pairs
#30ANTI-ADENOSINE RECEPTOR (A2aR) ANTIBODIES
#31POLYPEPTIDES, PROTEIN COMPLEXES AND METHOD FOR MAKING SAME
#32ANTI-HUMAN NEUROTENSIN RECEPTOR 1 ANTIBODY AND USE THEREOF
#33GLP1R AGONIST NMDAR ANTAGONIST CONJUGATES
#34AGENT, USES AND METHODS FOR TREATMENT
#35Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs
#36ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF
#37Cannabinoid receptor type 1 (CB1) antibodies, encoding nucleic acid molecules thereof and methods of use thereof
#38Anti-sortilin antibodies and methods of use thereof
#39LIGANDS TARGED TO EPIDERMAL GROWTH FACTOR RECEPTORS AND COMPOSITIONS FOR USE IN TREATING TUMORS
#40MHC class I epitope delivering polypeptides
#41CHIMERIC AUTOANTIBODY RECEPTOR (CAAR) THAT BINDS AUTOANTIBODIES TARGETING THE CENTRAL NERVOUS SYSTEM IN NEUROLOGICAL AUTOIMMUNE DISEASE
#42De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals
#43GPCR HETEROMER INHIBITORS AND USES THEREOF
#44Methods and compositions relating to adenosine receptors
#45METHODS OF USE OF ANTI-SORTILIN ANTIBODIES FOR TREATING A DISEASE, DISORDER, OR INJURY
#46METHOD OF TREATMENT
#47METHODS OF INCREASING PROGRANULIN LEVELS USING ANTI-SORTILIN ANTIBODIES
#48METHODS OF USE OF ANTI-SORTILIN ANTIBODIES FOR TREATING A DISEASE, DISORDER, OR INJURY
#49Methods of diagnosing, determining the progression of, and treating a prostate cancer
#50Method of Selecting for Antibodies
#51Anti-NMDA receptor antibodies and methods of use
#52USE OF AN INHIBITOR OF NTSR1 ACTIVATION OR EXPRESSION FOR PREVENTING WEIGHT LOSS, MUSCLE LOSS, AND PROTEIN BLOOD LEVEL DECREASE IN SUBJECTS IN NEED THEREOF
#53PHARMACEUTICAL FOR PREVENTING AND/OR TREATING STRESS LOAD-RELATED DISEASE
#54AGENTS, USES AND METHODS FOR TREATMENT
#55Agent, uses and methods for treatment
#56GPCR HETEROMER INHIBITORS AND USES THEREOF
#57CILIA-TARGETING NANOPARTICLES
#58MHC class I epitope delivering polypeptides
#59ANTIBODIES SPECIFIC FOR NTSR1 AND USES THEREOF
#60Cannabinoid receptor type 1 (CB1) binding proteins and uses thereof
#61VARIANT NUCLEIC ACID LIBRARIES FOR ADENOSINE RECEPTORS
#62Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer
#63Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs
#64Methods for promoting myelination and for treating demyelinating diseases
#65CELL-TARGETING MOLECULES COMPRISING PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CARBOXY-TERMINAL MOIETIES
#66METHODS OF USE OF ANTI-SORTILIN ANTIBODIES
#67GPCR heteromer inhibitors and uses thereof
#68Novel method of treating dystonia
#69Diagnosis and therapy of multiple sclerosis
#70Isolated nucleic acids encoding anti-sortilin antibodies
#71Tumor-targeted agonistic CD28 antigen binding molecules
#72Agent, uses and methods for treatment
#73Anti-Sortilin antibodies and methods of use thereof
#74OR10H1 ANTIGEN BINDING PROTEINS AND USES THEREOF
#75Methods of screening compounds useful for treatment of a liver disease
#76IMMUNE MODULATORS FOR REDUCING IMMUNE-RESISTANCE IN MELANOMA AND OTHER PROLIFERATIVE DISEASES
#77VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS
#78GPCR heteromer inhibitors and uses thereof
#79MHC Class I Epitope Delivering Polypeptides
#80Anti-sortilin antibodies and methods of use thereof
#81Methods of increasing progranulin levels using anti-Sortilin antibodies
#82Methods of use of anti-Sortilin antibodies for treating a disease, disorder, or injury
#83Agents, uses and methods for treatment
#84NOVEL ANTIBODY USEFUL IN NEUROLOGICAL OR NEURODEGENERATIVE DISORDERS
#85Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment
#86Agent, uses and methods for treatment
#87Anti-sortilin antibodies and methods of use thereof
#88ANTIBODIES WHICH BIND TYPE I CANNABINOID RECEPTOR/ANGIOTENSIS II RECEPTOR HETEROMERS
#89ANTIBODY OR ANTIBODY FRAGMENT OF NON-IG SCAFFOLD BINDING TO A BINDING REGION OF AN ANTI-N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTIBODY
#90Methods and Pharmaceutical Compositions (NTSR1 Inhibitors) for the Treatment of Hepatocellular Carcinomas
#91Methods for detecting prostate cancer by determining the ratio of early to late endosomal markers
#92NOVEL MONOCLONAL ANTIBODY INHIBITORS TARGETING POTASSIUM CHANNEL KCNK9
#93VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS
#94HUMAN MONOCLONAL ANTIBODIES AGAINST OREXIN RECEPTOR TYPE 1
#95Human monoclonal antibodies against orexin receptor type 1
#96Substances and methods for the use in prevention and/or treatment in Huntington's disease
#97Anti-sortilin antibodies, uses and methods for treatment
#98Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural Disorders
#99NOGO Receptor-Mediated Blockade of Axonal Growth
#100Modulation of Activity of Neurotrophins
#101Method for detecting GABAA receptor autoantibodies
#102Anti-mGluR2 conformational single domain antibodies and uses thereof
#103Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties
#104AGENTS INHIBITING GRANULIN FOR TREATMENT OF CANCER
#105METHOD FOR DIAGNOSING AND MONITORING THE PRESENCE OF CANCER IN A HUMAN SUBJECT
#106Diagnosis and therapy of multiple sclerosis
#107DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#108Nucleic acids encoding polypeptides which disrupt D1-D2 dopamine receptor coupling and modulate function
#109Antibodies which bind type I cannabinoid receptor/angiotensin II receptor heteromers and methods of use
#110CELL-TARGETED MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS
#111Antibody useful in neurological or neurodegenerative disorders
#112METHOD FOR TREATING NEUROENDOCRINE CANCER
#113Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies
#114Lrp4/corin dopamine-producing neuron precursor cell marker
#115Modulation of the Interaction Between SorLA and GDNF-Family Ligand Receptors
#116Methods for diagnosing and treating neuroendocrine cancer
#117Method of treating motor neuron disease with an antibody that agonizes MuSK
#118Methods of treating pain by inhibition of VGF activity
#119Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders
#120Methods for diagnosing and treating neuroendocrine cancer
#121Methods for the prevention and/or treatment of memory impairment
#122Methods for modulating D1-D2 dopamine receptor coupling and function
#123Antibodies which bind type I cannabinoid receptor/angiotensis II receptor heteromers
#124TREATMENT OF NEUROLOGICAL OR NEURODEGENERATIVE DISORDERS
#125Targeting the neuromuscular junction for treatment
#126Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
#127Polypeptides and methods for modulating D1-D2 dopamine receptor interaction and function
#128Therapeutic Agent
#129Modulation of activity of neurotrophins
#130Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
#131RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies
#132NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR
#133Modulation of the Vps10p-domain for the treatment of cardiovascular disease
#134ANTIBODY BOUND SYNTHETIC VESICLE CONTAINING MOLECULES FOR DELIVER TO CENTRAL AND PERIPHERAL NERVOUS SYSTEM CELLS
#135Methods for diagnosing and treating neuroendocrine cancer
#136Antibodies directed to mGluR7
#137Therapeutic Agent
#138Nogo receptor-mediated blockade of axonal growth
#139Oxytocin Receptor Antagonists and Their Use for the Treatment of Pulmonary Related Diseases
#140Assays utilizing nicotinic acetylcholine receptor subunits
#141METHOD FOR REDUCING ALLERGEN-INDUCED AIRWAY HYPERRESPONSIVENESS
#142METHOD OF DIAGNOSING A NEURODEGENERATIVE DISEASE
#143Antibodies to the alpha-7 nicotinic receptors and methods of treating inflammatory disorders with the same
#144Use of effector-function-deficient antibodies for treatment of auto-immune diseases
#145RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies
#146Hepatitis C virus inhibitors
#147Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor
#148Tomoregulin-2-antibody compositions and methods for the diagnosis and treatment of Alzheimer's disease
#149Nogo receptor-mediated blockade of axonal growth
#150Lrp4/Corin Dopaminergic Neuron Progenitor Cell Markers
#151Human Neuropeptide Receptor
#152Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor
#153Modulation of activity of neurotrophins
#154Method and apparatus for collaborative system
#155Method of screening for agents that modulate a homer signaling pathway
#156Mutation associated with epilepsy
#157Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor
#158Vanilloid receptor-2 ligands for treating anxiety or depression
#159Immunotoxin derived from a recombinant human autoantibody and method of using thereof
#160Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders
#161Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and activity
#162Human 5-HT3-C protein
#163Therapeutic use of selective LXR modulators
#164Methods for weight reduction
#165Methods for treating cancer using GRM8 inhibitors
#166Multi-functional particles and methods of using the same